Objective The aim of this study is to compare labor outcomes across race/ethnicity in women undergoing prostaglandin labor induction. Methods Secondary analysis of misoprostol vaginal insert (MVI) trial, a double-blind, randomized, control trial of 1,308 patients comparing sustained release vaginal inserts containing dinoprostone 10 mg and misoprostol 50 mcg (MVI 50) or 100 mcg (MVI 100). Results Achievement of active labor and induction failures were similar across race/ethnicity. Cesareans were performed less frequently in whites (29 %) and Hispanics (24.5 %) compared to blacks (32.7 %) (adjusted odds ratio (aOR) 0.87, 95 % confidence interval (CI) 0.47-0.97, p= 0.03 and aOR 0.86, 95 % CI 0.44-0.97, p=0.03, respectively). When compared to blacks, whites were less likely to undergo cesarean for non-reassuring fetal heart rate tracing (aOR 0.41, 95 % CI 0.25-0.66, p = 0.0003), as were Hispanics (aOR 0.38, 95 % CI 0.22-0.65, p= 0.0004). Postpartum hemorrhage occurred more frequently in Hispanics (8.8 %) versus blacks (4.1 %) and whites (OR 2.27, 95 % CI 0.23-0.82, p=0.02 and OR 3.69, 95 % CI 0.14-0.51, p<0.0001, respectively). Birth weights of black infants were lower than whites (p < 0.0001) and Hispanics (p = 0.0003). Neonatal outcomes did not differ between groups. Conclusion Differences in labor induction outcomes with prostaglandin labor induction exist based on race/ethnicity. Blacks delivered smaller babies, were more likely to undergo cesarean, and have cesareans performed for non-reassuring fetal heart tracing compared to other groups. Hispanics were more likely to experience postpartum hemorrhage compared to the other races.
Introduction
Significant racial and ethnic disparities exist throughout health care and are particularly evident in obstetrics where differences have been well established in all aspects of pregnancy care. These disparities have persisted over time and profoundly impact maternal and infant outcomes, future pregnancy care, and health care costs. Many studies have sought to clarify the causes of these disparities by examining socioeconomic status, environmental exposures, genetic predisposition, maternal stress, infection, and differences in provision of health care [2, [6] [7] [8] . However, accurately measuring outcomes and identifying quality indicators with respect to racial/ ethnic differences have been difficult due to the varying definitions of disparities used throughout the literature and the vast amount of potential confounding factors [7] . This is reflected in the relatively few standardized measures of quality obstetric care, such as time of entry into prenatal care, and has prompted investigation into other potential quality indicators such as cesarean delivery rate, postpartum hemorrhage and puerperal infection [2, 7, 9] . Just as a woman who entered spontaneous labor has a different risk profile than one who underwent an induction, these outcomes are intimately linked to a woman's health status at the time of labor and what occurred intrapartum.
This secondary analysis sought to address differences in intrapartum variables and labor outcomes based on race/ ethnicity in women undergoing induction of labor with misoprostol or dinoprostone vaginal inserts and suggests possible causes. Vital to all investigation into racial disparities is the goal of revealing modifiable differences above and beyond those that can be explained by differences in health status between groups. This study focused mainly on intrapartum and outcome variables in an attempt to identify if there was a more immediate temporal relationship between any of the disparities identified or if the modifiable aspects were based on prelabor factors such as prenatal exposures, genetic predisposition, and social or behavioral factors. In this population of women undergoing induction of labor with prostaglandins, we hypothesized that women of color would have disproportionately poorer outcomes when compared to white women including higher cesarean rates, more postpartum hemorrhage, and greater rates of puerperal infection after controlling for possible confounders. We also hypothesized that some historically persistent disparities would again be noted such as smaller babies born to black mothers.
Methods
The study was a secondary analysis of the data collected from the misoprostol vaginal insert (MVI) randomized control trial [10] . The original trial, Miso-Obs-004, was a multisite, double-blind, randomized study comparing the efficacy and safety of three different sustained release removable vaginal inserts containing dinoprostone 10 mg, misoprostol 50 mcg (MVI 50), or misoprostol 100 mcg (MVI 100). Forty-nine institutions across 24 states and 3 Canadian provinces participated in the trial, and 1,308 patients were enrolled from April 26, 2006 to August 7, 2007 . The Institutional Review Board at the University of California Irvine approved the study.
Enrollment criteria, induction indication definitions, and a more detailed description of the methods for this study can be found in the original publication of the MVI trial [10] . In brief, participants in the original study were recruited locally at each site from investigators' private practices, referrals from other attending physicians, and obstetric clinics. The participants were aged at least 18 years, of low parity (3 or less) with singleton pregnancies, and at least 36 weeks 0 days of gestation. They had no conditions requiring urgent delivery and required cervical ripening defined as baseline modified Bishop score of 4 or less. The admitting physician recorded the indication for induction. Participants were excluded if labor or vaginal delivery was contraindicated, delivery was deemed to be urgent, or sensitivity to either misoprostol or dinoprostone was known.
The original MVI trial presented the data on 1,308 patients using an intent-to-treat analysis. Wing et al. concluded that the median time intervals to vaginal delivery for both the MVI 100 mcg and the dinoprostone 10 mg vaginal insert were similar, whereas the MVI 50 mcg had a significantly longer time to vaginal delivery [10] . The three removable inserts were also found to have similar safety profiles as well as cesarean rates. The current analysis was confined to the 1,274 patients with sufficient outcome data who completed the study and delivered during their first admission. The study sponsor (Controlled Therapeutics (Scotland) Ltd.) used all available data collected in the course of the trial to construct a comprehensive database that was made available to the current authors for secondary analyses.
Maternal race/ethnicity was recorded as stated by the patient upon admission as white, black, Hispanic, Asian, Pacific Islander, or others. In all, there were 587 patients who identified themselves as white, 245 as black, 363 as Hispanic, 32 as Asian, and 47 as others. Given the small number of participants classified as Asian, Pacific Islander, and others, meaningful comparison could not be undertaken, and as such, these races were excluded from this secondary analysis.
Following study enrollment, an examination was performed to confirm vertex fetal presentation and to determine baseline modified Bishop score. Modified Bishop score was calculated again at 12 h after study drug insertion. Time to delivery was determined as the interval from insertion of the study drug to delivery of the fetus. Primary reason for discontinuation of the study drug insert included onset of active labor, study drug falling out of the vagina, completion of the 24-h dosing period and/or maternal-fetal complications. Removal of study drug after 24 h without evidence of active labor was categorized as "failed induction" in final analysis. Active labor was defined as at least three firm, rhythmic contractions lasting at least 45 s within a 10-min period or achievement of at least 4-cm dilatation. Frequency, duration, and amount of predelivery oxytocin use were recorded. Adverse events were recorded for both the mother and her neonate. These included a variety of outcomes such as postpartum hemorrhage, uterine contractile abnormalities, and side effects to the medication (maternal), as well as such neonatal outcomes as admission to the neonatal intensive care unit (NICU), hypoglycemia and hyperbilirubinemia. Differences between the treatment arms based on race were not examined as the subject number in each of the groups did not allow for meaningful comparison.
Statistical analyses were performed using JMP 9.0 (SAS Institute Inc., Cary, NC) statistical software, and all tests were conducted at the 0.05 significance level. Race/ethnicity was the basis of this comparison. Continuous variables were evaluated using Student's t tests where appropriate for normally distributed data or Wilcoxon rank-sum test for nonparametric data. Means were compared between multiple race/ethnicity pairs using ANOVA and Tukey-Kramer HSD method. Categorical variables were evaluated using χ 2 test, Fisher's exact test, Mann-Whitney U, or other tests as appropriate.
Results
Data from 1,274 patients was analyzed, of which 46 % identified themselves as white, 28 % as Hispanic, 19 % as black, and 6 % as others, Asian, or Pacific Islander. As stated above, the Asians, Pacific Islanders and participants describing themselves as other were excluded, thus 1,195 women were included. There was normal distribution of the races among the different treatment groups. Table 1 describes participant characteristics.
As shown in Table 1 , maternal age varied significantly by race, with black participants being of the lowest mean age (24.9 ±5.6; Hispanic 25.6±5.7, and whites 27.1±5.9). The mean age for whites was significantly older than Hispanics (p=0.002) and blacks (p=<0.0001); however, there was no significant difference between Hispanics and blacks (p=0.28). Body mass index (BMI) was calculated using maternal weight at time of admission for induction. Prepregnancy BMI and total weight gain in pregnancy were not available from all participants so was not included in the analysis. Black women had a higher mean BMI than whites or Hispanics though this was only significant when blacks were compared to whites (p = <0.0001). There was a higher proportion of white women in the BMI <30 group (38.8 %) compared to blacks (25.3 %), and there were more Hispanic women in the BMI 30-40 group compared to other races/ethnicities. The largest proportion of the BMI >40 group were black women (22.4 %). Nulliparity was encountered more often in white women (66.3 %) than Hispanics (57.6 %) or blacks (57.6 %), (p=0.008).
Significant differences (p<0.0001) between the races were noted when reason for induction was analyzed, with elective being the most common, with 56.4 % of whites, 48.6 % of blacks, and 44.4 % of Hispanics induced electively. Hypertensive disorders of pregnancy (hypertension and preeclampsia) as a group were the next most common reasons for Nonetheless, this significant difference in baseline modified Bishop score did not affect the odds of reaching active labor, as seen in Table 2 , and this analysis was not affected by adjusting for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score (data not shown). Additionally, time in active labor and time to delivery did not differ significantly by race/ethnicity (see Table 3 ). However, as seen in Table 2 , black women were less likely than white women to require oxytocin and were more likely to deliver by cesarean compared to Hispanic women. After adjusting for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score, the lower odds of requiring oxytocin for blacks relative to whites (adjusted odds ratio (aOR) 0.68, 95 % confidence interval (CI) 0.46-0.94, p=0.02) and the lower rate of cesarean among Hispanics compared to blacks (aOR 0.86, 95 % CI 0.44-0.97, p=0.03) remained significant. Additionally, after such adjustments were made, whites were also less likely to deliver by cesarean relative to blacks (aOR 0.87, 95 % CI 0.47-0.97, p= 0.03). When compared to blacks, whites were less likely to undergo cesarean for non-reassuring fetal heart rate tracing (aOR 0.41, 95 % CI 0.25-0.66, p=0.0003), as were Hispanics (aOR 0.38, 95 % CI 0.22-0.65, p = 0.0004). White women were less likely to deliver in 12 h versus the other races (Hispanics (OR 0.53, 95 % CI 0.34-0.83, p = 0.01), and blacks (OR 0.44, 95 % CI 0.27-0.71, p=0.01), but this significant difference was not noted at 24 h. These findings for delivery within 12 h remained significant after adjustment for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score (whites versus Hispanics, aOR 0.54, 95 % CI 0.34-0.88, p=0.01; whites versus blacks, aOR 0.40, 95 % CI 0.25-0.68, p=0.0007). Chorioamnionitis and endometritis were diagnosed more often in Hispanic women than white women, and this difference remained after adjustment for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score for both chorioamnionitis (whites versus Hispanics aOR 0.34, 95 % CI 0.18-0.62, p=0.0004) and endometritis (whites versus Hispanics aOR 0.29, 95 % CI 0.09-0.88, p=0.03) ( Table 2 ). There was no difference in puerperal infection noted between black and Hispanic women. Additionally, Hispanics had a greater odds of postpartum hemorrhage compared to blacks (aOR 2.41, 95 % CI 1.19-5.28, p=0.01) and compared to whites (aOR 3.69, 95 % CI 0.14-0.51, p<0.0001).
This greater risk of infection and postpartum hemorrhage did not significantly affect maternal length of stay (Table 3) nor were neonatal outcomes affected (Table 4 ). There were no significant differences between 5-min APGAR scores, the proportion of neonates with a 5-min APGAR less than 7, the proportion of neonates admitted to the intensive care unit (NICU), duration of stay in the NICU, or the proportion of neonates suffering any sort of adverse event. Black neonates were significantly lower in weight compared to white (p= <0.0001) or Hispanic neonates (p =0.0003). Data presented as mean±standard deviation or n (%).
Discussion
We found significant differences in antepartum variables and intrapartum outcomes between the racial and ethnic groups included in this investigation of labor induction. Differences in intrapartum care-sensitive conditions including birth weight, rate of cesarean delivery, puerperal infection, and postpartum hemorrhage were noted and persisted after adjustment for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score. White women included in this study tended to be older than the black and Hispanic women and were also more often nulliparous. Gestational age also differed with black and white mothers delivering at younger gestational ages than Hispanics. It is unclear if this is clinically significant as all of the participants were ≥36 weeks and there were no differences noted in neonatal outcomes. The analysis was also not powered to look at more rare outcomes related to differences between late preterm and term infants. We also found that differences existed between the groups for indications for induction, such as a higher frequency of diabetes in Hispanics and hypertensive complications in both blacks and whites compared to other groups. It could be hypothesized that the lower gestational ages of blacks and whites at delivery could be related to this higher rate of hypertensive disorders for which earlier delivery is often indicated; however, the number of subjects in these groups is too small to come to any compelling conclusions in this regard. It should also be noted here that guidelines recommending against elective induction prior to 39 weeks had not yet been instituted at the time of this study [11] [12] [13] . Although the vast majority of patients that underwent elective induction did so after 39 weeks, this point is important to highlight. More white patients underwent elective induction versus blacks or Hispanics (56 % versus 44 and 49 %, respectively). It is unclear why this difference exists and some possible reasons explored in previous literature include physician bias, patient request, or regional differences in practice. Further exploration of these differences is warranted particularly in light of more current recommendations against elective delivery prior to 39 weeks [12] .
Baseline Bishop score was also found to be statistically different though this is very unlikely to be clinically significant as all participants had a Bishop score of <4. Blacks had the lowest baseline Bishop score but significantly less black women received oxytocin. Some previous studies have attempted to establish a racial/ethnic difference in biochemical responses and pharmacologic variations based upon subtle molecular differences among race/ethnicities [14] . These include differences in molecular messaging pathways and receptor responses including those involved in differing responsiveness to prostaglandins such as dinoprostone and misoprostol. There has also been some exploration of differing responsiveness to prostaglandins in obese versus normal weight women [15] [16] [17] . Martinez et al. demonstrated that a higher BMI was associated with higher PGE2 levels in the rectal mucosa and postulated that PGE2 synthesis and response may be different in these patients [17] . Pevzner et al. also found that obese women who underwent induction with prostaglandins had a longer duration of labor, higher oxytocin requirement, and cesarean delivery rates [16] . The complete mechanism for these differences in obese women has not been characterized, and it could be hypothesized that there are differing rates of metabolism of certain prostaglandins or that there is some competitive inhibitor produced in these women that blunts the response to prostaglandins. It is also possible that there could be a selection bias in effect given that obesity disproportionally affects women of color. In this study, women with a BMI of 30-40 were more often Hispanic, and women with a BMI >40 were more often black. It is difficult to say whether the response to prostaglandins or to induction of labor itself is blunted by race, by BMI, or by a combination of the two. Most likely is that numerous factors affect the outcome, and these may not be able to ever be separated due to the inability to control for all variables. Although there has not been literature published on differing racial/ethnic response to prostaglandins in labor, there has been literature citing differing cytokine and inflammatory factor concentrations between races and the possible effects on preterm labor rates [18, 19] . It is possible that genetic variation may be a more significant modifier on the ability to successfully and safely induce women. These studies present a possible avenue for further research on whether there is a basis for similar findings based on race/ethnicity. Consistent with previous literature, black women in this study were found to have statistically smaller infants relative to other race/ethnicities [3, 4, 7, 8, 20] . Similar disparities in birth weight were described by Martin et al., who reported that blacks have a near 2-fold increase in low birth weight and a near 3-fold increase in very low birth weight infants compared to other race/ethnicities [20] . Birth weight is not affected by prostaglandin labor induction, so this variable was sought for a general comparison as this has been such an important measure of racial and ethnic disparity in the literature. Multiple factors have been cited as possible contributors to low birth weight in children of minority women including maternal health status prior to pregnancy and pregnancy weight gain, substance abuse, and exposure to certain environmental toxins have been associated with fetal growth restriction [8, 20, 21] . However, the effect of these exposures and health issues is not always consistent across races and even within certain racial/ethnic groups based upon their acculturation, country of birth, or spatial relationship to the USA [3, [22] [23] [24] . The CDC reported in 2002 that foreign born women had better outcomes than their US born racial/ethnic counterparts with regard to infant mortality, birth weight, and preterm birth rate despite later initiation of prenatal care and less education [3] . Interestingly, the difference in outcomes between foreign born and US born Latinas in particular has been shown to decrease with acculturation [25] .
The majority of studies have demonstrated that higher cesarean rates exist among minority populations even after adjusting for known risk factors [1, 6, [26] [27] [28] [29] . Chung et al. showed that compared with white patients, black patients were 75 % and Hispanic patients were 22 % more likely to undergo primary cesarean delivery [6] . Bryant et al. also observed a 1.48 and 1.19 times greater risk of cesarean delivery for African-Americans and Latina women respectively after adjustment for known risk factors [1] . After adjustment for age, race, parity, BMI, gestational age at admission, and baseline modified Bishop score, our results demonstrated a lower risk of cesarean delivery for both white women and Hispanic women compared to blacks but no significant difference between Hispanic and white women. In previous reports, Hispanics were often found to have lower cesarean rates when compared to other women of color from similar socioeconomic statuses, a phenomenon often referred to as the Hispanic paradox, which was supported by our findings [2, 23, 30] . Many researchers have attempted to identify the causes of this fairly consistent disparity though it appears to be related to multiple factors and may be further compounded by factors unable to be characterized or well measured. The increasing prevalence of maternal obesity has influenced multiple areas of obstetric care and impacted both maternal and neonatal outcomes. The risk of cesarean delivery is known to be increased in obese women of all races and women that have greater than recommended weight gain during pregnancy [31] [32] [33] [34] though not many studies have addressed the combined effect of both race and obesity on the risk of cesarean delivery [31, 35, 36] . The majority of reproductive age women in the USA are now overweight or obese with disproportionately more women of color affected. Marshall et al. in their evaluation of 312,412 women confirmed previous findings of increased risk of cesarean delivery in both obese Caucasian and obese African-Americans compared to their normal weight counterparts [31] . Interestingly though, they did note that there were no differences in the rate of cesarean delivery between the obese Caucasians compared to the obese African-Americans [31] . This was in contrast to findings by Steinfeld et al. in 2,424 women who found an increased cesarean rate in both obese Hispanic and AfricanAmerican women compared to obese white women [36] . Marshall et al. also found that there were persistent disparities among the neonates of obese mothers that had been demonstrated in infants of normal weight mothers. The neonates of the obese African-Americans were less likely to be macrosomic and more likely to be of low birth weight compared to the neonates of obese Caucasian women [31] . Our results showed that women of color were more often overweight or obese when compared with white women; however, a difference in cesarean rates was only noted between black women and other races. This suggests that there is an etiology beyond the contribution of obesity. There is also more recent literature in response to the 2009 Institute of Medicine guidelines for weight gain in pregnancy and the role of prepregnancy BMI, delivery BMI, weight gain in pregnancy, and even changes in BMI throughout pregnancy [37, 38] . It is evident that these are all potential variables that influence outcomes though the weight of their impact is not completely known. Black women were delivered for nonreassuring fetal heart rate tracing (NRFHRT) more often in comparison to other groups in our study, a finding that parallels the higher rate of fetal growth restriction in black women. It is plausible that black women have a predisposition to differences in placentation or antepartum uteroplacental flow that leads to a higher rate of fetal growth restriction. This chronic fetal nutritive and respiratory deprivation may predispose these fetuses to NRFHRT and thus cesarean delivery suggesting the root cause of the disparities demonstrated were factors that play well before entry into labor and perhaps well before conception. This study also occurred prior to current guidelines regarding categorization of fetal heart rate tracings [39, 40] . Although it was unable to be examined fully in this study, there may be bias in how these fetal tracings are differentially interpreted among the physicians and staff caring for these women. Fetal heart rate tracing interpretation is also fraught with both interobserver and intraobserver variation, so this may not ever be adequately explored. It is most likely that these differences result from multiple causes including biologic makeup of the individual as well as external influences such as provider bias and other practice differences.
Other quality measures including rates of postpartum hemorrhage and puerperal infection have been found to be higher in certain races. Previous studies show Hispanic women to have higher rates of postpartum hemorrhage when compared to other races [41, 42] . Our findings were consistent with this and showed a 3.7-fold and a 2.4-fold increased risk of postpartum hemorrhage in Hispanic women compared to whites and blacks, respectively. Puerperal infection rates have also been shown to be higher among women of color compared to white women [5, 41] ; however, we only found an increased rate of chorioamnionitis and endometritis in Hispanic women relative to whites and no increased risk for blacks. The higher rate of postpartum hemorrhage could be in part related to the higher rate of chorioamnionitis, a known risk factor for postpartum hemorrhage but would not be adequate to explain the significant difference noted. There was no difference in length of active labor or time to delivery between the groups. However, there were more Hispanic women induced for ruptured membranes, as well as oligohydramnios (almost twice the rate as for white women), and it is conceivable that this oligohydramnios reflects an even greater proportion of women with ruptured membranes, a known risk factor for chorioamnionitis. It is unclear what the etiology of these differences is as puerperal infections would be expected to be higher in black women given the higher rate of cesarean delivery which is a risk factor for both hemorrhage and infection. On the contrary, we found that both puerperal infection and postpartum hemorrhage were more common in Hispanic women despite similarities in length of labor among the races. Again, this suggests an etiology beyond known contributors and may be an inherent racial/ethnic difference that should help modify obstetric care. Nonetheless, duration of maternal stay was not significantly affected by this higher rate of postpartum hemorrhage and infection nor was neonatal outcomes significantly different for Hispanics compared to other race/ethnicity groups.
A limitation of this study is that aspects of acculturation and general socioeconomic statuses were not included. Other limitations include variable obstetric practices in this large, multicenter study, unknown baseline cesarean rates at specific hospitals, and breakdowns of site-specific influences that were not taken into account due to an inability to incorporate these factors in a practicable manner. The absence of standardized definitions for induction indications across all 49 centers presented an issue with regard to postdates induction as well as impending macrosomia as the subjects were enrolled and the data collected prior to most hospitals adopting more stringent criteria for inducing women. However, patients have been recategorized in compliance with ACOG recommendations as described in Practice Bulletin 107 [43] . The main limitation of this study, however, is that it is a secondary analysis that was not powered specifically for differences in outcomes based on race/ethnicity but rather to look at outcomes for the different cervical ripening treatment groups. Though differences among racial/ethnic groups were not the primary outcomes of the initial study, multiple outcome variables were collected and presented a unique opportunity to evaluate the outcomes assessed in the secondary analysis.
A strength of this report is the incorporation of confounding factors such as body mass indices and morbidities associated with obesity into the secondary analyses. These factors affect the US population as a whole and often disproportionately affect black and Hispanic populations [5, 31, 32, 34, 35, 44, 45] . The races in this analysis were compared to each other as well as well as to whites as a reference group, and results emphasize the existence of interracial differences. Another asset of this evaluation is that the data were collected from 49 diverse sites across the USA and Canada during one of the largest prospective, double-blinded trials on prostaglandin induction using a standardized protocol increasing external validity and minimizing provider bias that has often been cited for differences in medical care. The original study was a prospective randomized controlled trial in which women who presented after 36 weeks 0 days that required cervical ripening were approached for participation thus eliminating selection bias and controlling for known and unknown confounding factors.
The literature is replete with reports of significant medical and obstetrical disparities based on race and ethnicity. These disparate outcomes and differences in health care challenge practitioners to address these disparities and attempt to identify possible practice strategies to better care for a diverse patient population. The causes of these disparities are largely unknown and are often multifactorial. It is apparent from previous literature that some of these factors may be modifiable but that many will be predetermined and may be helpful as risk counseling points. This report attempts to highlight persistence of disparities despite controlling for confounders and offer further avenues of research to better characterize differences between races. Given the multiple modifiers of antenatal, intrapartum, and postpartum health, it would be impossible to offer an exclusive cause for these disparities, and research should be focused on discovery of those disparities that may be amenable to change. Knowledge of these inherent differences between groups could help to identify a particular patient's risk factors, aid in provision of better health care, provide a safer delivery environment, and ultimately improve maternal and fetal outcomes of women affected by race-related morbidity.
